Yadav Bhawna, Mora-Montes Héctor M, Wagener Jeanette, Cunningham Iain, West Lara, Haynes Ken, Brown Alistair J P, Gow Neil A R
The Aberdeen Fungal Group, School of Medicine, Medical Sciences & Nutrition, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK.
Department of Biosciences, University of Exeter, Geoffrey Pope Building, Stocker Road, Exeter EX4 4QD, UK.
Cell Surf. 2020 Jul 21;6:100042. doi: 10.1016/j.tcsw.2020.100042. eCollection 2020 Dec.
We designed experiments to assess whether fungal cell wall mannans function as an immune shield or an immune agonist. Fungal cell wall β-(1,3)-glucan normally plays a major and dominant role in immune activation. The outer mannan layer has been variously described as an immune shield, because it has the potential to mask the underlying β-(1,3)-glucan, or an immune activator, as it also has the potential to engage with a wide range of mannose detecting PRRs. To resolve this conundrum we examined species-specific differences in host immune recognition in the 1Δ mannosylation-deficient mutant background in four species of yeast-like fungi. Irrespective of the fungal species, the cytokine response (TNFα and IL-6) induced by the 1Δ mutants in human monocytes was reduced compared to that of the wild type. In contrast, TNFα production induced by 1Δ was increased, relative to wild type, due to increased β-glucan exposure, when mouse or human macrophages were used. These observations suggest that -mannan is not a major PAMP for macrophages and that in these cells mannan does shield the fungus from recognition of the inner cell wall β-glucan. However, -mannan is a significant inducer of cytokine for monocytes. Therefore the metaphor of the fungal "mannan shield" can only be applied to some, but not all, myeloid cells used in immune profiling experiments of fungal species.
我们设计了实验来评估真菌细胞壁甘露聚糖是作为一种免疫屏障还是免疫激动剂发挥作用。真菌细胞壁β-(1,3)-葡聚糖通常在免疫激活中起主要和主导作用。外层甘露聚糖层被描述为免疫屏障,因为它有可能掩盖潜在的β-(1,3)-葡聚糖;也被描述为免疫激活剂,因为它也有可能与多种检测甘露糖的模式识别受体相互作用。为了解决这个难题,我们在四种酵母样真菌的1Δ甘露糖基化缺陷突变体背景下,研究了宿主免疫识别中的物种特异性差异。无论真菌种类如何,与野生型相比,1Δ突变体在人单核细胞中诱导的细胞因子反应(TNFα和IL-6)均降低。相反,当使用小鼠或人巨噬细胞时,由于β-葡聚糖暴露增加,1Δ诱导的TNFα产生相对于野生型增加。这些观察结果表明,甘露聚糖不是巨噬细胞的主要病原体相关分子模式,并且在这些细胞中,甘露聚糖确实保护真菌不被识别内部细胞壁β-葡聚糖。然而,甘露聚糖是单核细胞细胞因子的重要诱导剂。因此,真菌“甘露聚糖屏障”的比喻仅适用于真菌物种免疫分析实验中使用的部分而非全部髓样细胞。